This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 3, Multicenter, Randomized, Double-Blind, ...
Clinical trial

A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 50 mg Compared With Sitagliptin 100 mg When Used in Combination With Metformin in Subjects With Type 2 Diabetes

Read time: 1 mins
Last updated:11th Jun 2013
To evaluate the efficacy of TAK-875 plus metformin compared with sitagliptin plus metformin on glycemic control as measured by change from Baseline in glycosylated hemoglobin (HbA1c) over a 24-week Treatment Period.
Category Value
Study start date 2013-06-11

View full details